-
Mashup Score: 0Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies - 11 month(s) ago
May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company’s key electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. All data were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society, held in New Orleans from May 19-21. Real-world outcomes from the EU-PORIA registry…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
@DAICeditor @BSCCardiology Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the #FARAPULSE Pulsed Field #Ablation System: https://t.co/qoURMixDDb #HRS23